Loading
1 insider bought €1.6M of shares over the last 90 days, the latest by Dalmia Bharat Refractories Limited, filed 01 Oct 2026.
Dalmia Bharat Limited: what insiders have been doing
Dalmia Bharat Limited belongs to the Chemicals sector. Filings by its managers are published through SEBI (PIT + SAST). 9 insiders have disclosed 12 filings since 26 October 2025.
Open-market activity splits into 1 purchase totalling €1.6M and 1 sale totalling €1.6M; 1 insider sit on the buying side and 1 insider on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 1 major shareholder. One trade stands out by size: a sale of €1.6M from Rama Investment Company Private Limited, disclosed on 1 October 2026, or 0.054% of market capitalisation.
The clock since the last published purchase (1 October 2026) now reads 25 days. Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
For context, the typical company on the same exchange (median of 1,891 companies) published 4 filings over the same period, against 12 filings here. Looking back to 2021, when coverage begins, insiders filed 3 purchases and 14 sales.
In the same sector, recent insider purchases at Titan and Norske Skog ASA also feature in our signals. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Insider Decl.
31
Thresholds
n/a
Buy Volume
€2M
3 ops. · all time
Sell Volume
€2M
14 ops. · all time
Who traded when
BuySaleDalmia Bharat Refractories Limited1 buy
Rama Investment Company Private Limited1 sale
Since the insiders bought
- -27.5%Entry ₹1,768.80 · Close at T+365 ₹1,282.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Dalmia Bharat Limited Buy (bullish), based on 34 analysts. Average price target: ₹2,127.47.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,498 of 26,320 companies
54.8
score / 100
Value49
Quality60
FCF yld0.7%
Earn yld3.8%
EV/EBITDA11.3x
ROE6.5%
Gross mgn63%
Net mgn7.9%
Debt/EBITDA2.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹1,591.30
Analyst consensus
34 analystsBuy
₹1,800.00Target ₹2,127.47(+34%)₹2,500.00
Income statement
Revenue₹144.7B
Gross profit₹91.5B63% margin
EBITDA₹32.9B23% margin
Net income₹11.4B6.2% margin
Valuation
PER (trailing)31.3x
PER (forward)22.2x
P/Book1.7x
Beta0.19
Balance sheet & cash
Market cap₹298.7B
Total debt₹74.1B
Free Cash Flow₹2.2B
Debt / Equity41%
Profitability & ownership
ROE6.5%
ROA3.4%
% insiders60.5%
% institutions29.5%
Last declaration on 1 October 2026
Declarations31 total
1,084,000 shares@ ₹1,700.000.58% mcap91.6% of flowEquityInter-se-TransferSEBI:86b439807c280f78b08873b21f0fca552f162878
100,000 shares@ ₹1,700.800.054% mcap21.9% of flowEquityMarket SaleSEBI:82dd3d6d3f78afe0cd083b3be462f8ada6bcab9a
100,000 shares@ ₹1,700.800.054% mcap8.4% of flowEquityMarket PurchaseSEBI:0bbfc2524c0d1d829c971f63b4e792087091ff3a
Canonical exit: 30 Dec 2026 (T+90)
357,000 shares@ ₹1,700.000.19% mcap78.1% of flowEquityInter-se-TransferSEBI:14169bbb75e8510e3cd955424b7190452978bf7a
727,000 shares@ ₹1,700.000.39% mcap100.0% of flowEquityInter-se-TransferSEBI:42bc2aca8d21bc17828d3dc43b172de6301b6235
359,710 shares0EquityInter-se-TransferSEBI:9fab91d9de806c3f28bddedb6735821bb9b9283c
359,710 shares0EquityInter-se-TransferSEBI:0bc9ace81ceea389a16a78b5d641b5eaa9734321
1,290,773 shares-Scheme Of AmalgamationSEBI:ae85642af7e90aea53fb592a311cd7c790a3be8d
1,290,773 shares00.0% of flowEquityScheme of Amalgamation/Merger/Demerger/ArrangementSEBI:ffbca149a4e47781e9f3290ee26b2ff22b7b8aac
333,000 shares@ ₹1,798.000.18% mcap100.0% of flowEquity SharesSEBI:96bd87f1725ea4f51627ad75531038ab242df2d7
388,000 shares@ ₹1,801.550.21% mcap100.0% of flowEquity SharesSEBI:8add48bdc74227abef7f10254944ed81e28c596c
721,000 shares@ ₹1,799.91040.39% mcap100.0% of flowEquity SharesSEBI:db9ef76c538ed79e709b5d879a7dc050f186301f
67,335,614 sharesEquity SharesSEBI:bbcbb6fbe45821afc7f104e4670fcd32c30eae15
100,000 shares@ ₹2,030.00100.0% of flowEquity SharesSEBI:d836c1af03f01d318205d6bd2ea6b52e176e4e3b
1,312,444 shares@ ₹2.00100.0% of flowEquity SharesSEBI:f765277c3b1f6d18eba64d5b43cee862701c3087
698,952 sharesEquity SharesSEBI:71af8a2e44c391ffb6afdf5693726b7e3d6b59b0
1,000 shares@ ₹2,150.000.0008% mcap60.7% of flowEquity SharesSEBI:bbafe86aea499a91b7b892c47b07461f00fd81ab
300 shares@ ₹1,890.000.0002% mcap13.7% of flowEquity SharesSEBI:c57e46f5dbcfb100976d379725c2e4884fabedda
500 shares@ ₹1,899.900.0003% mcap100.0% of flowEquity SharesSEBI:da03b90dad5fc625a1cc0104054f33d79c389956
200 shares@ ₹1,875.000.0001% mcap9.1% of flowEquity SharesSEBI:1ee448dc63be312552641198762c878a473a0c95
600 shares@ ₹1,847.96330.0004% mcap32.2% of flowEquity SharesSEBI:cdb5b0a7e1690ff1135425e400b18e01a2b0b9d8
1,000 shares@ ₹1,806.36540.1% of flowEquity SharesSEBI:21e66b8339c76599adc7602e45c328701dafca4f
Canonical exit: 1 Sept 2021 (T+90)
1,500 shares@ ₹1,803.6259.9% of flowEquity SharesSEBI:f34ca36b3dbd9ed24089b70ea5345d8d68b9e7c3
Canonical exit: 30 Aug 2021 (T+90)
200 shares@ ₹1,896.200.0001% mcap11.0% of flowEquity SharesSEBI:d28946a3e269c8d35da09ca8a2425ce254412bcb
1,100 shares@ ₹1,784.81640.0007% mcap56.8% of flowEquity SharesSEBI:cf86bcfe8321e7985eda899add2af572cbe90bda
25 of 31 declarations
About Dalmia Bharat Limited
Dalmia Bharat Limited is an Indian company operating in the construction materials sector, primarily cement. It is listed on the Bombay Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
